Immy MDX Ltd

Active08956760 Private limited company

Incorporated: 25 March 2014 (12 years)
Previously known as: Olm Diagnostics Limited (until 10 May 2024)
This list may be incomplete. See all names on Companies House
Industry: Research and experimental development on biotechnology (72110)
Directors: Timothy Allen Heefner
Sean Kevin Bauman
Owned by: Okuk Holdings Ltd
Accounts type: Small
Region: East of England
Address: Suite 14
Cornwallis House
Howard Chase
Basildon
SS14 3BB

Filing status

Accounts due: 31 March 2028
Last accounts: 30 June 2026
Conf. stmt due: 14 June 2027
Last conf. stmt: 31 May 2026

Officers 2 active

Officer details are public data from the Companies House register.

Heefner, Timothy Allen

Director · Appointed 7 May 2024

American

Born September 1971 (55)

Bauman, Sean Kevin

Director · Appointed 7 May 2024

Also at Okuk Holdings Ltd

American

Born November 1971

Officer history (3 former)

31 October 2024

Resigned Mcgonnell, Gerard as Director

7 May 2024

Appointed Heefner, Timothy Allen as Director

7 May 2024

Appointed Bauman, Sean Kevin as Director

7 May 2024

Resigned Johnson, Gemma as Director

20 June 2019

Resigned Thompson, Robert Frazer as Director

18 July 2018

Appointed Johnson, Gemma as Director

15 October 2014

Appointed Mcgonnell, Gerard as Director

25 March 2014

Appointed Thompson, Robert Frazer as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Okuk Holdings Ltd

Corporate entity · Notified 6 April 2016

Owns 75–100% of shares

Limited Company

Reg. no. 08953513

Former controllers (2)

7 May 2024

Ceased Robert Frazer Thompson — Has significant influence or control

7 May 2024

Ceased Gerard Mcgonnell — Has significant influence or control

Financials

Figures from 2025 accounts. Newer accounts, made up to 30 June 2026, are filed but not read yet. See them on Companies House

Net Assets: £423,451
Cash: £272,804
Profit: £329,491

Debt Ratio: 36%
Current Ratio: 2.8x
Return on Equity: 78%

Trend

Net Assets

Balance sheet detail

	2025	2024	2023	2022	2021	2021	2020
Fixed Assets	£23,000	£28,500	£31,146	£32,499	£32,741	£34,023
Current Assets	£635,176	£781,867	£842,238	£516,991	£245,520	£228,248	£136,606
Debtors	£286,339	£100,952	£178,491	£124,674	£115,639	£93,716	£75,814
Cash	£272,804	£653,544	£603,505	£382,725	£114,973	£122,254	£36,546
Creditors (< 1 year)	£230,663	£1,084,362	£243,560	£158,783	£168,028	£345,964	£265,301
Creditors (> 1 year)		£0	£77,439	£117,439	£181,858	£42,500
Net Current Assets	£404,513	(£302,495)	£598,678	£358,208	£77,492	(£117,716)	(£128,695)
Net Assets	£423,451	(£279,215)	£546,601	£268,831	(£71,625)	(£126,193)	(£113,911)
Shareholder Funds	£423,451	(£279,215)	£546,601	£268,831	(£71,625)		(£113,911)